TransMedics Group shares rose after the FDA granted conditional approval for a clinical trial of its Next-Generation OCS ENHANCE Heart system, designed to improve organ preservation for transplants.

#TMDX #TMDXStock #TMDXNews #TMDXStockNews #TransMedics #TransMedicsStock #TransMedicsNews